1,145,072 Shares in Revvity, Inc. (NYSE:RVTY) Purchased by Norges Bank

Norges Bank purchased a new stake in Revvity, Inc. (NYSE:RVTY) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 1,145,072 shares of the company’s stock, valued at approximately $127,801,000. Norges Bank owned about 0.94% of Revvity at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in the business. Cerity Partners LLC lifted its stake in Revvity by 7.4% during the third quarter. Cerity Partners LLC now owns 17,130 shares of the company’s stock valued at $2,188,000 after purchasing an additional 1,174 shares during the last quarter. FMR LLC increased its holdings in shares of Revvity by 40.8% in the third quarter. FMR LLC now owns 155,556 shares of the company’s stock valued at $19,872,000 after buying an additional 45,040 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Revvity by 23.7% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 37,805 shares of the company’s stock valued at $4,830,000 after acquiring an additional 7,237 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of Revvity by 7.7% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 684,078 shares of the company’s stock worth $87,391,000 after acquiring an additional 48,700 shares in the last quarter. Finally, Public Sector Pension Investment Board grew its holdings in shares of Revvity by 14.9% in the 3rd quarter. Public Sector Pension Investment Board now owns 5,383 shares of the company’s stock worth $688,000 after acquiring an additional 700 shares during the last quarter. Institutional investors own 86.65% of the company’s stock.

Insider Transactions at Revvity

In other Revvity news, insider Tajinder S. Vohra sold 5,492 shares of the stock in a transaction on Tuesday, January 7th. The shares were sold at an average price of $116.81, for a total transaction of $641,520.52. Following the transaction, the insider now directly owns 19,652 shares of the company’s stock, valued at $2,295,550.12. This represents a 21.84 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Joel S. Goldberg sold 15,170 shares of the business’s stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $126.73, for a total value of $1,922,494.10. Following the completion of the sale, the insider now directly owns 33,400 shares of the company’s stock, valued at $4,232,782. This represents a 31.23 % decrease in their position. The disclosure for this sale can be found here. 0.68% of the stock is currently owned by company insiders.

Revvity Price Performance

RVTY opened at $105.83 on Tuesday. The stock has a fifty day moving average price of $114.91 and a 200 day moving average price of $117.04. The company has a current ratio of 3.60, a quick ratio of 3.03 and a debt-to-equity ratio of 0.41. Revvity, Inc. has a 1 year low of $97.32 and a 1 year high of $129.50. The stock has a market cap of $12.72 billion, a price-to-earnings ratio of 47.89, a PEG ratio of 3.82 and a beta of 1.06.

Revvity (NYSE:RVTY) last announced its quarterly earnings results on Friday, January 31st. The company reported $1.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.37 by $0.05. Revvity had a return on equity of 7.68% and a net margin of 9.81%. During the same quarter last year, the business posted $1.25 earnings per share. Analysts forecast that Revvity, Inc. will post 4.94 EPS for the current fiscal year.

Revvity Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Friday, April 18th will be paid a dividend of $0.07 per share. The ex-dividend date is Thursday, April 17th. This represents a $0.28 annualized dividend and a dividend yield of 0.26%. Revvity’s dividend payout ratio (DPR) is 12.67%.

Analyst Ratings Changes

Several brokerages have recently commented on RVTY. Raymond James reaffirmed an “outperform” rating and set a $145.00 target price (up from $140.00) on shares of Revvity in a report on Monday, February 3rd. Sanford C. Bernstein cut shares of Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 target price for the company. in a report on Friday, January 10th. Barclays boosted their price target on shares of Revvity from $135.00 to $140.00 and gave the company an “overweight” rating in a report on Monday, February 3rd. Bank of America raised shares of Revvity from a “neutral” rating to a “buy” rating and set a $138.00 price objective for the company in a research note on Friday, December 13th. Finally, KeyCorp increased their target price on Revvity from $132.00 to $145.00 and gave the company an “overweight” rating in a report on Monday, February 3rd. Four research analysts have rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Revvity has an average rating of “Moderate Buy” and a consensus price target of $136.25.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.